CareDx Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
22,098.00
26,806.00
28,144.00
40,631.00
48,324.00
76,569
Cost of Goods Sold (COGS) incl. D&A
9,078.00
7,975.00
10,273.00
21,122.00
22,371.00
33,987
Gross Income
13,020.00
18,831.00
17,871.00
19,509.00
25,953.00
42,582
SG&A Expense
13,877.00
16,854.00
28,629.00
39,976.00
43,109.00
57,143
EBIT
857.00
1,977.00
10,758.00
20,467.00
17,156.00
14,561
Unusual Expense
500.00
725.00
1,774.00
17,115.00
33,034.00
29,775
Non Operating Income/Expense
36.00
13.00
188.00
1,920.00
1,116.00
178
Interest Expense
2,149.00
1,984.00
987.00
1,860.00
5,963.00
3,701
Pretax Income
3,542.00
719.00
13,707.00
41,362.00
57,269.00
48,215
Income Tax
-
1,500.00
-
1,606.00
1,709.00
1,434
Consolidated Net Income
3,542.00
781.00
13,707.00
39,756.00
55,560.00
46,781
Net Income
3,542.00
781.00
13,707.00
39,469.00
55,469.00
46,756
Net Income After Extraordinaries
3,542.00
781.00
13,707.00
39,469.00
55,469.00
46,756
Net Income Available to Common
3,542.00
781.00
13,707.00
39,469.00
55,469.00
46,756
EPS (Basic)
0.29
0.10
1.16
2.39
2.38
1.31
Basic Shares Outstanding
12,170.60
5,815.90
11,860.90
16,496.90
23,332.50
35,639
EPS (Diluted)
0.29
0.10
1.16
2.39
2.38
1.31
Diluted Shares Outstanding
12,170.60
9,283.00
11,860.90
16,496.90
23,332.50
35,639
EBITDA
194.00
2,489.00
9,962.00
17,547.00
13,397.00
10,346
Minority Interest Expense
-
-
-
287.00
91.00
25

About CareDx

View Profile
Address
3260 Bayshore Boulevard
Brisbane California 94005
United States
Employees -
Website http://www.caredxinc.com
Updated 07/08/2019
CareDx, Inc. operates as a transplant diagnostics company, which offers pre- and post-transplant continuum. It focuses on discovery, development, and commercialization of diagnostic surveillance solutions. Its product includes AlloMap, which aids clinicians in identifying heart transplant recipients with stable allograft function and AlloSure, which is a donor-derived cell free DNA test.